<bill session="108" type="s" number="891" updated="2023-01-15T23:33:09Z">
  <state datetime="2003-04-11">REFERRED</state>
  <status>
    <introduced datetime="2003-04-11"/>
  </status>
  <introduced datetime="2003-04-11"/>
  <titles>
    <title type="display">Prescription Drug Equity for Seniors Act of 2003</title>
    <title type="official" as="introduced">A bill to provide substantial reductions in the price of prescription drugs for medicare beneficiaries.</title>
    <title type="short" as="introduced">Prescription Drug Equity for Seniors Act of 2003</title>
  </titles>
  <sponsor bioguide_id="J000177"/>
  <cosponsors/>
  <actions>
    <action datetime="2003-04-11">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-04-11" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Ambulatory care"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Governmental investigations"/>
    <term name="Life expectancy"/>
    <term name="Medicare"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Social Welfare"/>
    <term name="Terminal care"/>
    <term name="Terminally ill"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in Senate">Prescription Drug Fairness for Seniors Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make it available for purchase by each pharmacy: (1) in an amount equal to the aggregate amount of the drug sold or distributed by the pharmacy to Medicare beneficiaries; and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug. Sets forth special provisions with respect to hospice programs.</summary>
</bill>
